Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:12 pm Sale | 2023-12-31 | 13G | Sintx Technologies, Inc. SINT | Lind Global Fund II LP | 0 0.000% | -4,325 (Position Closed) | Filing History |
| 2024-02-13 8:12 pm Sale | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 28 0.100% | -39 (-57.95%) | Filing History |
| 2024-02-13 8:12 pm Purchase | 2023-12-31 | 13G | Revelation Biosciences, Inc. REVB | Lind Global Fund II LP | 3,885 2.900% | 3,756 (+2900.00%) | Filing History |
| 2024-02-13 8:11 pm Sale | 2023-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 3,125 6.000% | -1,000 (-24.24%) | Filing History |
| 2024-02-13 8:11 pm Purchase | 2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 251,770 9.900% | 251,770 (New Position) | Filing History |
| 2024-02-13 8:10 pm Sale | 2023-12-31 | 13G | Polar Power, Inc. POLA | Lind Global Fund II LP | 3,917 0.200% | -138,940 (-97.26%) | Filing History |
| 2024-02-13 8:10 pm Unchanged | 2023-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 8:10 pm Sale | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 10,557 1.700% | -38,997 (-78.70%) | Filing History |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Fund II LP | 125,520 3.900% | 125,520 (New Position) | Filing History |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ | Lind Global Fund II LP | 405,000 9.900% | 405,000 (New Position) | Filing History |
| 2024-02-13 8:08 pm Purchase | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 93,889 9.900% | 55,499 (+144.57%) | Filing History |
| 2024-02-13 8:08 pm Purchase | 2023-12-31 | 13G | Intelligent Bio Solutions Inc. INBS | Lind Global Fund II LP | 960,000 9.900% | 927,833 (+2884.46%) | Filing History |
| 2024-02-13 8:06 pm Purchase | 2023-12-31 | 13G | GSE Systems, Inc. GVP | Lind Global Fund II LP | 300,568 9.900% | 300,568 (New Position) | Filing History |
| 2024-02-13 8:06 pm Sale | 2023-12-31 | 13G | Grom Social Enterprises, Inc. GROM | Lind Global Fund II LP | 0 0.000% | -12,004 (Position Closed) | Filing History |
| 2024-02-13 8:05 pm Purchase | 2023-12-31 | 13G | Energy Focus, Inc. EFOI | Lind Global Fund II LP | 117,508 2.600% | 117,508 (New Position) | Filing History |
| 2024-02-13 8:05 pm Purchase | 2023-12-31 | 13G | Edible Garden AG Incorporated EDBL | Lind Global Fund II LP | 1,144 9.900% | 744 (+185.91%) | Filing History |
| 2024-02-13 8:05 pm Sale | 2023-12-31 | 13G | CEA Industries Inc. CEAD | Lind Global Fund II LP | 34,583 4.900% | -11,658 (-25.21%) | Filing History |
| 2024-02-13 8:04 pm Purchase | 2023-12-31 | 13G | Blue Star Foods Corp. BSFC | Lind Global Fund II LP | 31,800 9.900% | 31,800 (New Position) | Filing History |
| 2024-02-13 8:04 pm Purchase | 2023-12-31 | 13G | BIO-key International, Inc. BKYI | Lind Global Fund II LP | 46,285 4.700% | 46,285 (New Position) | Filing History |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ | Lind Global Fund II LP | 9,210 0.400% | 9,210 (New Position) | Filing History |